Two studies presented at the 20thInternational AIDS Conference this week in Melbourne showed that all-oral regimens of direct-acting antiviral agents for hepatitis C are safe and effective for HIV positive people. Both regimens demonstrated sustained virological response rates similar to those seen in people with HCV alone.
-- Sofosbuvir + Ribavirin Cures More Than 80% of HIV/HCV Coinfected People
-- AbbVie 3D Regimen Cures Most Genotype 1 HIV/HCV Coinfected Patients